Hearing the words “you have cancer” is devastating and life-changing. Getting an accurate diagnosis, and choosing a doctor and treatment facility for your cancer care is an important step in getting the best treatment possible. No one chooses when they will get cancer. No one chooses where they will get cancer, but everyone has a choice when it comes to choosing your cancer care team. UofL Health – Brown Cancer Center leads multidisciplinary teams of sub-specialty experts, including those with UofL Physicians – Medical Oncology.
When you are facing a cancer diagnosis, it is nice to know that you are not alone. At Brown Cancer Center you will be surrounded by a team of warm and compassionate medical experts who will answer your questions, help you make decisions about your next steps, as well as understand and address your fears.
Our medical oncologists see patients at Brown Cancer Center, where we practice as part of multidisciplinary teams of sub-specialists. These teams, which include medical oncologists, hematologists, surgeons, radiation oncologists, radiologists, pathologists and other specialists develop an individualized, comprehensive treatment plan for each patient.
We use sophisticated technologies and the latest combination of therapies to provide each patient with an individual comprehensive treatment plan. We carefully monitor each patient’s treatment and provide follow-up care. We also can help patients manage the side effects of drug therapy so patients can lead relatively normal lives while undergoing treatment.
Diseases and conditions
- Brain and spine tumors
- Breast cancer
- Gastrointestinal cancer
- Genitourinary cancer, cancers that affect the urinary tract, bladder, kidneys, prostate, testicles and penis
- Gynecologic cancer, cancers that affect the female reproductive organs – including the cervix, fallopian tubes, ovaries, uterus, vagina and vulva
- Head and neck cancers
- Cancers of the blood and blood disorders (Leukemia, lymphomas, multiple myeloma)
- Lung cancer
Treatments and services
A medical oncologist often is the main health care provider for someone who has cancer. If you have been diagnosed with cancer, you may need drug therapy for treatment, or following surgery to kill any remaining cancer cells. This usually involves a combination of two or more drugs that enter the bloodstream and travel throughout the body. This means you will need to see a medical oncologist, which is a doctor who specializes in diagnosing and treating cancer using chemotherapy, hormonal therapy, biological therapy, targeted therapy and innovative immunotherapy options.
Your medical oncologist with will work a multidisciplinary team to come with up with a precise, targeted plan personalized for you, your specific type of cancer and your lifestyle needs. Our goal is to have everyone and everything we need in place so that we can provide you with the highest quality of care available, whatever your needs might be.
Each clinic reflects the combined strength of groundbreaking research, leading-edge technology, accomplished specialists and exceptional collaborative care.
In addition, collaboration with clinical researchers and basic science researchers at the Brown Cancer Center provides the optimal setting for rapidly bringing new treatments to our patients. Our approach to medical oncology is deeply rooted in the Brown Cancer Center’s translational research findings, which focus on highly targeted therapies that dramatically reduce toxicity and harmful side effects.
Our patients are often among the first to benefit from new treatments through our robust clinical trial program. We were early adopters of immunotherapy and we were the top center in the world to test the combination of agents that prime the immune system (oncolytic viruses) and agents that expand the immune system (immune checkpoint inhibitors). Both of these two classes of immunotherapies are now approved by the Food and Drug Administration and have resulted in a more than ten-fold increase in the three-year survival of metastatic melanoma patients (from only 5 percent survival to 70 percent survival after three years). This same research has been found to reduce deaths for more than a dozen other types of cancer.